These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31038865)

  • 1. lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion.
    Zhang C; Wang W; Lin J; Xiao J; Tian Y
    Int Braz J Urol; 2019; 45(3):549-559. PubMed ID: 31038865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
    Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
    Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-148a-3p inhibits the proliferation and migration of bladder cancer
    Xu C; Zhou G; Sun Z; Zhang Z; Zhao H; Jiang X
    PeerJ; 2022; 10():e12724. PubMed ID: 35127282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CCAT1 sponges miR-218-5p to promote EMT, cellular migration and invasion of retinoblastoma by targeting MTF2.
    Meng X; Zhang Y; Hu Y; Zhong J; Jiang C; Zhang H
    Cell Signal; 2021 Oct; 86():110088. PubMed ID: 34265414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.
    Yang T; Zhai H; Yan R; Zhou Z; Gao L; Wang L
    Braz J Med Biol Res; 2018; 51(6):e7046. PubMed ID: 29791590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
    Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
    Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Long Noncoding RNA LUCAT1 Suppresses the Migration and Invasion of Bladder Cancer by Targeting miR-181c-5p.
    Chen Y; Zhang W; Shen L; Kadier A; Huang J; Wang R; Wu P; Yao X
    Biomed Res Int; 2020; 2020():4817608. PubMed ID: 33282949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.
    Pu J; Wu X; Wu Y; Shao Z; Luo C; Tang Q; Wang J; Wei H; Lu Y
    Aging (Albany NY); 2021 Mar; 13(8):12207-12223. PubMed ID: 33952719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression.
    Wang W; Shen F; Wang C; Lu W; Wei J; Shang A; Wang C
    Tumour Biol; 2017 Jun; 39(6):1010428317698383. PubMed ID: 28618950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3.
    Sun S; Liu F; Xian S; Cai D
    Med Sci Monit; 2020 Jun; 26():e920331. PubMed ID: 32512576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.
    Lai XJ; Cheng HF
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):322-328. PubMed ID: 29424889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer.
    Hu X; Feng H; Huang H; Gu W; Fang Q; Xie Y; Qin C; Hu X
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819846638. PubMed ID: 31311442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion.
    Xue M; Li X; Li Z; Chen W
    Tumour Biol; 2014 Jul; 35(7):6901-12. PubMed ID: 24737584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.
    Cai X; Dai Y; Gao P; Ren G; Cheng D; Wang B; Wang Y; Yu J; Du Y; Wang X; Xue B
    Aging (Albany NY); 2021 Jul; 13(14):18527-18544. PubMed ID: 34319909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
    Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.